|
|
Office Locations:
|
105 Continental Place, Suite 350
Brentwood, TN 37027
| |
|
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Solas BioVentures is a biotechnology and medical device venture capital fund founded by Casey Hammontree in 2014. Hammontree is currently a partner at Tenth Street Capital. Solas BioVentures focuses on early stage biopharmaceuticals, medical devices, diagnostics, digital health technologies and related opportunities in medicine.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
